Health

Lawmakers pitch bill to create $30 billion in drug development ‘biobonds’


In a bid to jumpstart drug development, a bipartisan group of lawmakers introduced a bill for the U.S. government to back so-called “biobonds,” which would be used to fund small companies and universities that are researching treatments for unmet medical needs.

The LOANS Act, which would authorize a total of $30 billion over an upcoming three-year period, is designed to reduce what the lawmakers called a “perennial shortage of funds” and to help restart research stalled by the Covid-19 pandemic.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED


Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button